Charles Schoch

Insider Reports History

Location
Needham, MA
Signature
/s/ Charles Schoch
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Schoch:

Company Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. Chief Financial Officer Common Stock 43,391 $202,635 $4.67 25 Jun 2025 Direct
Candel Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 232,000 26 Jan 2026 Direct

Insider Reports Filed by Charles Schoch

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CADL Candel Therapeutics, Inc. 26 Jan 2026 1 $0 4 Chief Financial Officer 28 Jan 2026, 17:02
CADL Candel Therapeutics, Inc. 25 Jun 2025 1 +$24,999 4 Chief Financial Officer 26 Jun 2025, 08:30
CADL Candel Therapeutics, Inc. 20 Jun 2025 1 $0 4 Chief Financial Officer 24 Jun 2025, 16:30
CADL Candel Therapeutics, Inc. 17 Mar 2025 1 -$44,169 4 Interim Chief Financial Officer 19 Mar 2025, 16:06
CADL Candel Therapeutics, Inc. 12 Feb 2025 1 $0 4 Interim Chief Financial Officer 14 Feb 2025, 16:30
CADL Candel Therapeutics, Inc. 15 Jan 2025 1 -$68,717 4 Interim Chief Financial Officer 17 Jan 2025, 16:30
CADL Candel Therapeutics, Inc. 08 Jan 2025 1 -$81,944 4 Interim Chief Financial Officer 10 Jan 2025, 16:30
CADL Candel Therapeutics, Inc. 17 Jul 2024 1 -$63,975 4 Interim Chief Financial Officer 19 Jul 2024, 08:28
CADL Candel Therapeutics, Inc. 11 Jul 2024 1 -$53,145 4 Interim Chief Financial Officer 15 Jul 2024, 08:34
CADL Candel Therapeutics, Inc. 12 Jan 2024 0 $0 3 Interim Chief Financial Officer; Exhibit 24 - Power of Attorney 19 Jan 2024, 08:30